report.object
AI infrastructure for life sciences data and labs
Expert-reviewed from public records, platform data, primary sources, and private research beyond AI search. Use /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/sample before purchase, then download PDF, JSON, or Markdown after checkout.
page.markdown
AI infrastructure for life sciences data and labs.md
# AI infrastructure for life sciences data and labs
Life-sciences AI infrastructure depends on which notebook methods, sample records, instrument files, omics runs and automation logs can cross into AI use while preserving source ownership, permissions, reviewer action and validation evidence.
## Object
| field | value |
| ---------------- | ------------------------------ |
| report_id | RPT_01KSHN11BYPHQYZYV4EJK3NYY8 |
| schema_version | 2026-05-28 |
| last_updated_at | 2026-06-01 |
| category | INFRA |
| sector | Life sciences |
| region | GLOBAL |
| confidence_score | 0.85 |
| source_count | 30 |
| evidence_count | 31 |
## Endpoints
| action | endpoint |
| ------------ | --------------------------------------------------------- |
| summary | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8 |
| sample | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/sample |
| schema | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/schema |
| quote | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/quote |
| purchase | /checkout/RPT_01KSHN11BYPHQYZYV4EJK3NYY8?view=agent |
| versions | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/versions |
| changelog | /api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/changelog |
| monitor | /api/v1/monitors?report_id=RPT_01KSHN11BYPHQYZYV4EJK3NYY8 |
| mcp_resource | colophon://reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/sample |
## Coverage
| field | value |
| -------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| category | INFRA |
| sector | Life sciences |
| region | GLOBAL |
| topics | life sciences AI, ELN, LIMS, SDMS, omics, bioinformatics workflows, lab automation, cloud labs, GxP validation, computer software assurance, 21 CFR Part 11, EU Annex 11, data lineage, scientific data standards, IP boundaries |
| source_classes | fda_guidance, regulation, regulatory_guidance, industry_standard, glp_guidance, vendor_docs, product_docs, lab_data_standard, lab_automation_standard, lab_automation_docs, case_study, research_paper, omics_cloud_docs, omics_platform_docs, workflow_platform_docs, data_access_policy, data_access_standard, data_standard, data_lineage_standard |
| update_cadence | Weekly |
## Sample JSON
```json
{
"report_id": "RPT_01KSHN11BYPHQYZYV4EJK3NYY8",
"slug": "ai-infrastructure-life-sciences-data-labs",
"schema_version": "2026-05-28",
"title": "AI infrastructure for life sciences data and labs",
"abstract": "Life-sciences AI infrastructure depends on which notebook methods, sample records, instrument files, omics runs and automation logs can cross into AI use while preserving source ownership, permissions, reviewer action and validation evidence.",
"category": "INFRA",
"sector": "Life sciences",
"region": "GLOBAL",
"topics": [
"life sciences AI",
"ELN",
"LIMS",
"SDMS",
"omics",
"bioinformatics workflows",
"lab automation",
"cloud labs",
"GxP validation",
"computer software assurance",
"21 CFR Part 11",
"EU Annex 11",
"data lineage",
"scientific data standards",
"IP boundaries"
],
"last_updated_at": "2026-06-01T00:00:00Z",
"source_count": 30,
"evidence_count": 31,
"confidence_score": 0.85,
"web_url": "/r/ai-infrastructure-life-sciences-data-labs/RPT_01KSHN11BYPHQYZYV4EJK3NYY8",
"sample_endpoint": "/api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/sample",
"inventory_endpoint": "/api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/inventory",
"full_endpoint": "/api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/full",
"schema_endpoint": "/api/v1/reports/RPT_01KSHN11BYPHQYZYV4EJK3NYY8/schema",
"redaction": {
"status": "sample",
"paid_sections_redacted": true,
"preview_limits": [
"summary",
"table_of_contents",
"evidence_profile"
]
},
"coverage": {
"category": "INFRA",
"sector": "Life sciences",
"region": "GLOBAL",
"topics": [
"life sciences AI",
"ELN",
"LIMS",
"SDMS",
"omics",
"bioinformatics workflows",
"lab automation",
"cloud labs",
"GxP validation",
"computer software assurance",
"21 CFR Part 11",
"EU Annex 11",
"data lineage",
"scientific data standards",
"IP boundaries"
],
"source_classes": [
"fda_guidance",
"regulation",
"regulatory_guidance",
"industry_standard",
"glp_guidance",
"vendor_docs",
"product_docs",
"lab_data_standard",
"lab_automation_standard",
"lab_automation_docs",
"case_study",
"research_paper",
"omics_cloud_docs",
"omics_platform_docs",
"workflow_platform_docs",
"data_access_policy",
"data_access_standard",
"data_standard",
"data_lineage_standard"
]
},
"confidence": {
"overall_confidence": 0.85,
"source_quality": 0.88,
"source_recency": 0.88,
"source_density": 0.84,
"claim_verifiability": 0.85,
"geographic_coverage": 0.8,
"known_gaps": [
"Public evidence is limited for like-for-like validation effort across lab-informatics, scientific data cloud, omics workflow and automation routes.",
"Vendor-authored case studies often show workflow shape without independent ROI, baseline or denominator.",
"Controlled-access genomics and partner-data permissions vary by consent, contract and jurisdiction.",
"Comparable cost per accepted scientific output is rarely published across software, compute, validation, reviewer and rework costs.",
"Self-driving lab evidence is strongest in research demonstrations and weaker for routine GxP production use."
]
},
"document": {
"object": "report_document",
"schemaVersion": "2026-05-28",
"title": "AI infrastructure for life sciences data and labs",
"subtitle": "Approve which lab work can cross into AI use without losing lineage, rights or validation state.",
"abstract": "Life-sciences AI infrastructure depends on which notebook methods, sample records, instrument files, omics runs and automation logs can cross into AI use while preserving source ownership, permissions, reviewer action and validation evidence.",
"category": "INFRA",
"sector": "Life sciences",
"region": "GLOBAL",
"topics": [
"life sciences AI",
"ELN",
"LIMS",
"SDMS",
"omics",
"bioinformatics workflows",
"lab automation",
"cloud labs",
"GxP validation",
"computer software assurance",
"21 CFR Part 11",
"EU Annex 11",
"data lineage",
"scientific data standards",
"IP boundaries"
],
"sources": [
{
"id": "S1",
"label": "FDA - Computer Software Assurance for Production and Quality Management System Software",
"sourceClass": "fda_guidance",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.fda.gov/media/188844/download"
},
{
"id": "S2",
"label": "eCFR - 21 CFR Part 11",
"sourceClass": "regulation",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.ecfr.gov/current/title-21/chapter-I/subchapter-A/part-11"
},
{
"id": "S3",
"label": "FDA - Data Integrity and Compliance With Drug CGMP",
"sourceClass": "fda_guidance",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/data-integrity-and-compliance-drug-cgmp-questions-and-answers"
},
{
"id": "S4",
"label": "EMA - Guideline on computerised systems and electronic data in clinical trials",
"sourceClass": "regulatory_guidance",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.ema.europa.eu/en/human-regulatory-overview/research-development/compliance-research-development/good-clinical-practice/good-clinical-practice-inspectors-working-group"
},
{
"id": "S5",
"label": "European Commission - EU GMP Annex 11 draft update",
"sourceClass": "regulatory_guidance",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://health.ec.europa.eu/document/download/40231f18-e564-4043-94de-c031f813d38b_en"
},
{
"id": "S6",
"label": "ISPE - GAMP 5 Guide 2nd Edition",
"sourceClass": "industry_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://ispe.org/publications/guidance-documents/gamp-5-guide-2nd-edition"
},
{
"id": "S7",
"label": "ISPE - GxP Compliant Laboratory Computerized Systems guide",
"sourceClass": "industry_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://ispe.org/publications/guidance-documents/gamp-good-practice-guide-gxp-compliant-laboratory-computerized-systems"
},
{
"id": "S8",
"label": "OECD - Application of GLP Principles to Computerised Systems",
"sourceClass": "glp_guidance",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.oecd.org/en/publications/application-of-glp-principles-to-computerised-systems_e3c9cda5-en.html"
},
{
"id": "S9",
"label": "Benchling - Validated Cloud information",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://help.benchling.com/hc/en-us/articles/9684211689997-Benchling-Validated-Cloud-Information"
},
{
"id": "S10",
"label": "LabVantage - pharmaceutical and biotech LIMS",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.labvantage.com/industries/pharma-biotech/"
},
{
"id": "S11",
"label": "Thermo Fisher Scientific - SampleManager LIMS",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.thermofisher.com/us/en/home/digital-solutions/lab-informatics/lab-information-management-systems-lims/solutions/samplemanager.html"
},
{
"id": "S12",
"label": "Sapio Sciences - LIMS",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.sapiosciences.com/products/lims/"
},
{
"id": "S13",
"label": "TetraScience - scientific IT",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.tetrascience.com/solutions/scientific-it"
},
{
"id": "S14",
"label": "TetraScience - Tetra Data Platform overview",
"sourceClass": "product_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://developers.tetrascience.com/v4.3/docs/tetradata-science-platform-overview"
},
{
"id": "S15",
"label": "Ganymede - GxP instrument connectivity",
"sourceClass": "vendor_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.ganymede.bio/products/gxp"
},
{
"id": "S16",
"label": "Allotrope Framework technical reports",
"publisher": "Allotrope Foundation",
"sourceClass": "lab_data_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://docs.allotrope.org/"
},
{
"id": "S17",
"label": "SiLA - laboratory automation standards",
"sourceClass": "lab_automation_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://sila-standard.com/standards/"
},
{
"id": "S18",
"label": "Opentrons Flex documentation",
"publisher": "Opentrons",
"sourceClass": "lab_automation_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://docs.opentrons.com/flex/introduction/"
},
{
"id": "S19",
"label": "Emerald Cloud Lab",
"sourceClass": "case_study",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.emeraldcloudlab.com/"
},
{
"id": "S20",
"label": "Nature - Autonomous chemical research with large language models",
"sourceClass": "research_paper",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.nature.com/articles/s41586-023-06792-0"
},
{
"id": "S21",
"label": "AWS HealthOmics - service overview",
"sourceClass": "omics_cloud_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://docs.aws.amazon.com/omics/latest/dev/what-is-healthomics.html"
},
{
"id": "S22",
"label": "AWS HealthOmics - workflow runs",
"sourceClass": "omics_cloud_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://docs.aws.amazon.com/omics/latest/dev/running-workflows.html"
},
{
"id": "S23",
"label": "DNAnexus - GxP documentation",
"sourceClass": "omics_platform_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://documentation.dnanexus.com/admin/gxp"
},
{
"id": "S24",
"label": "Terra - security",
"sourceClass": "omics_platform_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://terra.bio/terra-security/"
},
{
"id": "S25",
"label": "Seqera - GxP-ready platform",
"sourceClass": "workflow_platform_docs",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://seqera.io/solutions/gxp/"
},
{
"id": "S26",
"label": "NIH - Genomic Data Sharing Policy",
"sourceClass": "data_access_policy",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://grants.nih.gov/grants/guide/notice-files/NOT-OD-14-124.html"
},
{
"id": "S27",
"label": "GA4GH - Data Use Ontology",
"sourceClass": "data_access_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.ga4gh.org/product/data-use-ontology-duo/"
},
{
"id": "S28",
"label": "Nature Scientific Data - FAIR Guiding Principles",
"sourceClass": "data_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.nature.com/articles/sdata201618"
},
{
"id": "S29",
"label": "W3C - PROV overview",
"sourceClass": "data_lineage_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://www.w3.org/TR/prov-overview/"
},
{
"id": "S30",
"label": "OpenLineage",
"sourceClass": "data_lineage_standard",
"accessedAt": "2026-06-01",
"status": "verified",
"access": "public",
"transformChain": [],
"url": "https://openlineage.io/"
}
],
"evidence": [
{
"id": "E1",
"sourceId": "S1",
"claimIds": [
"C4",
"C10"
],
"summary": "FDA's February 2026 revised CSA guidance recommends a risk-based approach for software assurance in medical-device production and quality management systems, including confidence in automation and fit-for-use testing.",
"status": "verified",
"confidence": 0.9,
"access": "sample"
},
{
"id": "E2",
"sourceId": "S2",
"claimIds": [
"C4"
],
"summary": "21 CFR Part 11 defines when electronic records and signatures are treated as trustworthy, reliable and generally equivalent to paper records and handwritten signatures.",
"status": "verified",
"confidence": 0.91,
"access": "sample"
},
{
"id": "E3",
"sourceId": "S3",
"claimIds": [
"C4"
],
"summary": "FDA's data-integrity guidance keeps CGMP attention on complete, consistent, accurate and retrievable records rather than the mere presence of a software feature.",
"status": "verified",
"confidence": 0.86,
"access": "sample"
},
{
"id": "E4",
"sourceId": "S4",
"claimIds": [
"C4"
],
"summary": "EMA's computerised-systems guidance for clinical trials took effect in September 2023 and gives sponsors, investigators and service providers a live standard for electronic trial data.",
"status": "verified",
"confidence": 0.86,
"access": "sample"
},
{
"id": "E9",
"sourceId": "S9",
"claimIds": [
"C1",
"C3",
"C4",
"C9"
],
"summary": "Validated Cloud: release cadence, audit trails, e-signatures and validation documentation.",
"status": "verified",
"confidence": 0.84,
"access": "sample"
},
{
"id": "E13",
"sourceId": "S13",
"claimIds": [
"C1",
"C3",
"C9",
"C10"
],
"summary": "Scientific IT: governed instrument data with metadata, lineage, audit trails and ELN, LIMS and LES integrations.",
"status": "verified",
"confidence": 0.82,
"access": "sample"
},
{
"id": "E20",
"sourceId": "S20",
"claimIds": [],
"summary": "The Coscientist paper demonstrates LLM-enabled scientific tasks that include planning, hardware-documentation navigation, cloud-lab commands, liquid-handler control, multi-module task execution and optimisation.",
"status": "verified",
"confidence": 0.86,
"access": "sample"
},
{
"id": "E21",
"sourceId": "S21",
"claimIds": [
"C1",
"C2",
"C6",
"C9",
"C10"
],
"summary": "AWS HealthOmics supports WDL, Nextflow and CWL workflows plus sequence, reference, variant and annotation stores for omics workflow infrastructure.",
"status": "verified",
"confidence": 0.85,
"access": "sample"
},
{
"id": "E22",
"sourceId": "S22",
"claimIds": [
"C1",
"C2",
"C6"
],
"summary": "AWS HealthOmics recommends using run UUIDs for provenance and to link workflow runs to internal LIMS or sample-tracking systems.",
"status": "verified",
"confidence": 0.87,
"access": "sample"
}
],
"claims": [
{
"id": "C1",
"statement": "The winning life-sciences AI infrastructure investment decides which notebook records, LIMS sample records, instrument files, omics runs and lab automation evidence may enter AI workflows without losing permissions or validation state.",
"confidence": 0.88,
"evidenceIds": [
"E9",
"E13",
"E20",
"E21",
"E22"
],
"access": "sample"
},
{
"id": "C2",
"statement": "Life-sciences laboratory infrastructure needs an evidence register for sample lineage, method execution, instrument raw data, omics consent, automation authority and GxP validation state.",
"confidence": 0.84,
"evidenceIds": [
"E1",
"E21",
"E22"
],
"access": "sample"
},
{
"id": "C3",
"statement": "ELN, LIMS, LES and SDMS products remain the system-of-record layer for experiments, samples, methods, inventory, execution and review; data-cloud projects should integrate with them rather than pretend to replace them at the first approval gate.",
"confidence": 0.87,
"evidenceIds": [
"E9",
"E13"
],
"access": "sample"
},
{
"id": "C4",
"statement": "GxP AI infrastructure needs risk-based computerised-system assurance, audit trails, electronic signatures, validated-state evidence and supplier documentation beyond secure cloud tenancy.",
"confidence": 0.9,
"evidenceIds": [
"E1",
"E2",
"E3",
"E4"
],
"access": "sample"
},
{
"id": "C6",
"statement": "Omics workloads require their own workflow lane because workflow languages, sequence stores, run identifiers, controlled-access genomic data and consent-linked use permissions are materially different from ELN notebook data.",
"confidence": 0.87,
"evidenceIds": [
"E21",
"E22"
],
"access": "sample"
},
{
"id": "C9",
"statement": "Buy validated system-of-record and workflow platforms where supplier evidence lowers validation burden, build only the lab-specific lineage and rights logic that differentiates the science, and self-host models only when data boundary or accepted-output economics justify it.",
"confidence": 0.85,
"evidenceIds": [
"E9",
"E13",
"E21"
],
"access": "sample"
},
{
"id": "C10",
"statement": "Model deployment should consume only lab evidence objects that carry source permissions, omics data rights, automation authority, validation evidence, lineage and IP boundaries.",
"confidence": 0.86,
"evidenceIds": [
"E1",
"E13",
"E20",
"E21"
],
"access": "sample"
}
],
"colophon": {
"checkedAt": "2026-06-01",
"latestRevisionAt": "2026-06-01T00:00:00Z",
"reviewStandard": "expert_human_reviewed",
"kinetics": {
"speed": "moderate",
"impact": 0.89,
"momentum": 0.77,
"businessImpact": "Lab AI infrastructure is now judged by how much notebook, sample, raw-file, omics and automation work can cross into AI use without losing lineage, rights or validation state.",
"rateOfChange": "Validation evidence can change before lab-system renewal when intended use, supplier releases, omics run provenance or consent inheritance shifts.",
"from": "compliance recordkeeping for lab systems",
"toward": "approved lab-work objects feeding governed AI use"
},
"watch": [],
"gapAnalysis": "An independent like-for-like benchmark or longitudinal telemetry set is missing for approval rate, validation effort, lineage repair, reviewer burden, failed runs, cost and accepted-output accuracy across the same lab-informatics, scientific-data-cloud, omics and automation workflow."
},
"body": {
"sections": [
{
"id": "executive-summary",
"title": "Executive summary",
"access": "sample",
"claimIds": [
"C1",
"C2",
"C3",
"C4",
"C9",
"C10"
],
"evidenceIds": [
"E1",
"E2",
"E4",
"E13",
"E20",
"E21",
"E22"
],
"blocks": [
{
"id": "executive-summary-narrative",
"evidenceIds": [
"E1",
"E2",
"E4",
"E13",
"E20",
"E21",
"E22"
],
"type": "section_narrative",
"lead": "The scarce control is lab-work survivorship.",
"body": [
"A notebook entry, sample record, raw file, omics run, automation log or partner dataset should cross into AI use only when sample identity, method version, run ID, consent or IP label, reviewer action and validation state remain attached.",
"Notebook expansion, LIMS modernization, data lakes, model workspaces and lab automation solve different control problems. Electronic notebooks protect methods and signatures; LIMS protects samples, tests and chain of custody; scientific data clouds normalize instrument files; omics platforms preserve run identity and consent; automation adds command authority. The infrastructure job is to join those proofs without hiding the formal record.",
"Regulated and quality-system workflows need provenance, permission, accountable review and a revalidation trigger; FDA CSA frames software assurance around intended use and risk-based evidence [E1]. Controlled-access genomic reuse also needs source rights and permission boundaries before AI use [E26].",
"The commercial decision is where to own the conversion logic that carries lab evidence into AI use. External platforms fit record lanes when supplier evidence lowers GxP work; proprietary science needs owned rules for assay interpretation, protocol variants, negative results, compound context, consent boundaries and partner-data terms."
],
"detail": [
"The first useful metric is the share of lab work that reaches AI without losing provenance, permission or validation state.",
"Vendor and standards sources show workflow shape; accepted-output economics require private measurement in the buyer's own lab."
]
},
{
"id": "scientific-memory-decision-table",
"title": "Lab-work approval decision",
"evidenceIds": [
"E1",
"E2",
"E4",
"E13",
"E20",
"E21",
"E22"
],
"type": "table",
"columns": [
{
"key": "question",
"label": "Question",
"align": "left"
},
{
"key": "answer",
"label": "Answer",
"align": "left"
},
{
"key": "buyer_move",
"label": "Action",
"align": "left"
}
],
"rows": [
{
"question": "What should be approved first?",
"answer": "The lab-work unit by data class and workflow: sample, method, raw file, run, automation command, reviewer action and rights label.",
"buyer_move": "Classify notebook, LIMS, SDMS, omics, instrument, automation and partner-data evidence separately."
},
{
"question": "Where should AI work begin?",
"answer": "With read-only evidence search over objects whose source, lineage, rights and reviewer rules are already clear.",
"buyer_move": "Pilot search, summarization and analysis before write-back, batch calculation or lab action."
},
{
"question": "What is the denominator?",
"answer": "The share of lab work that reaches AI with lineage, rights and validation state intact.",
"buyer_move": "Use the metric to separate external record platforms, owned conversion logic and model deployment timing."
},
{
"question": "Where should the platform boundary sit?",
"answer": "Validated systems of record where supplier evidence reduces validation burden; scientific-data layers where they improve raw-file and run reuse.",
"buyer_move": "Use external platforms for regulated records and commodity controls; own the lineage, rights and conversion logic specific to the science."
},
{
"question": "What should be blocked?",
"answer": "Unlabelled proprietary data, consent-limited genomics, GxP records without audit trails and automation commands without release authority.",
"buyer_move": "Block AI use until source, rights, lineage, owner and retest trigger are explicit."
}
]
},
{
"id": "scientific-memory-to-route-tree-bridge",
"evidenceIds": [
"E1",
"E2",
"E4",
"E13",
"E20",
"E21",
"E22"
],
"type": "paragraph",
"text": "The policy matters when it raises the share of reusable lab work and blocks data that has lost source, rights or validation state.",
"variant": "small"
},
{
"id": "lab-ai-route-tree",
"title": "Decision tree for lab AI",
"evidenceIds": [
"E1",
"E2",
"E4",
"E9",
"E13",
"E20",
"E21",
"E22"
],
"type": "decision_tree",
"lead": "Start with the lab-work unit. If the sample, method, run, rights and reviewer trail are incomplete, keep AI read-only or outside the workflow.",
"steps": [
{
"prompt": "Is the workflow GxP, clinical-trial, GLP, GMP or submission-supporting?",
"tone": "warning",
"branches": [
{
"label": "Yes",
"outcome": "Use a validated workflow with audit trail, e-signature, intended-use evidence and change control.",
"tone": "blocked"
},
{
"label": "No",
"outcome": "Continue to proprietary and consent boundaries.",
"next": "Q2 rights",
"tone": "neutral"
}
]
},
{
"prompt": "Does the data include proprietary protocols, compound structures, sequences, negative results or partner material?",
"tone": "warning",
"branches": [
{
"label": "Yes",
"outcome": "Use a controlled scientific workspace or private model channel with explicit retention and use limits.",
"tone": "warning"
},
{
"label": "No",
"outcome": "Use approved research-data paths and continue to lineage.",
"next": "Q3 lineage",
"tone": "info"
}
]
},
{
"prompt": "Can the workflow trace sample, method, instrument, run, transformation, reviewer and output?",
"tone": "warning",
"branches": [
{
"label": "Yes",
"outcome": "Pilot accepted-output tests and reviewer workflow.",
"tone": "success"
},
{
"label": "No",
"outcome": "Fix lineage before adding AI use or automation authority.",
"tone": "blocked"
}
]
},
{
"prompt": "Will the AI action touch a robot, instrument, batch record, regulated submission or external partner?",
"tone": "blocked",
"branches": [
{
"label": "Yes",
"outcome": "Require human approval, simulation evidence, command logs, rollback and incident playbooks.",
"tone": "blocked"
},
{
"label": "No",
"outcome": "Use read-only or analyst-in-the-loop workflows until the risk tier changes.",
"tone": "success"
}
]
}
]
}
]
},
{
"id": "decision-frame",
"title": "Decision frame",
"access": "sample",
"dek": "The decision object is approved lab evidence for research, development, quality and data reuse.",
"claimIds": [
"C1",
"C2",
"C3",
"C6",
"C10"
],
"evidenceIds": [
"E2",
"E9",
"E13",
"E21",
"E1"
],
"blocks": [
{
"id": "decision-frame-narrative",
"evidenceIds": [
"E2",
"E9",
"E13",
"E21"
],
"type": "section_narrative",
"lead": "Life-sciences AI infrastructure has five evidence objects: system record, scientific data product, workflow run, automation command and approved AI context.",
"body": [
"The record layer is ELN, LIMS, LES, SDMS, chromatography data systems and quality systems. The data-product layer normalises instrument files, assay outputs and metadata. The workflow layer handles omics and analysis runs. The automation layer executes or coordinates physical work. The model layer reasons over approved context.",
"One enterprise platform can cover several layers, but the evidence questions stay separate. Model use can be acceptable for public literature and blocked for proprietary assay design. A cloud omics workflow can be acceptable for research analysis [E21] and still insufficient for a regulated submission without validation evidence [E23].",
"Model serving, licence, GPU and retrieval economics matter only after the lab evidence object decides whether the model should see the data at all."
],
"detail": [
"The lab evidence converter preserves experiment records, omics consent labels, raw instrument files, method execution and GxP validation state as data moves into AI use."
]
},
{
"id": "route-lanes-table",
"title": "Evidence conversion by lab lane",
"evidenceIds": [
"E2",
"E9",
"E13",
"E21"
],
"type": "table",
"columns": [
{
"key": "lane",
"label": "Lane",
"align": "left"
},
{
"key": "source_of_truth",
"label": "Source of truth",
"align": "left"
},
{
"key": "ai_use",
"label": "AI use",
"align": "left"
},
{
"key": "approval_gate",
"label": "Approval gate",
"align": "left"
}
],
"rows": [
{
"lane": "ELN and experiment design",
"source_of_truth": "Notebook record, protocol, materials, attachments and signatures.",
"ai_use": "Search, protocol drafting, prior-experiment comparison and controlled write-back.",
"approval_gate": "Notebook role, e-signature need, audit trail and GxP intended use."
},
{
"lane": "LIMS, LES and quality control",
"source_of_truth": "Sample, inventory, method execution, specification, result and review state.",
"ai_use": "Exception triage, method assistance, release-support analysis and deviation drafting.",
"approval_gate": "Part 11 or Annex 11 controls, validation packet, reviewer queue and SOP fit."
},
{
"lane": "Instrument and SDMS layer",
"source_of_truth": "Raw files, parser output, metadata, calibration and source anchor.",
"ai_use": "Data harmonisation, table extraction, trend analysis and cross-instrument search.",
"approval_gate": "Raw-data preservation, parser validation, chain of custody and ontology fit."
},
{
"lane": "Omics workflow platform",
"source_of_truth": "Read set, reference, workflow, run UUID, container, variant or annotation store.",
"ai_use": "Pipeline troubleshooting, cohort analysis, variant annotation and research summarization.",
"approval_gate": "Consent label, controlled-access rule, workflow version, run provenance and compute policy."
},
{
"lane": "Lab automation and cloud lab",
"source_of_truth": "Command script, instrument state, run log, sample movement and result file.",
"ai_use": "Design-of-experiment support, protocol simulation, scheduling and constrained command generation.",
"approval_gate": "Simulation, physical safety, method lock, human approval and incident response."
},
{
"lane": "LLM and model-serving route",
"source_of_truth": "Approved AI context, retrieval source, gateway log and output review.",
"ai_use": "Reasoning, summarization, extraction, workflow guidance and agent orchestration.",
"approval_gate": "Approve licence, hosting, retrieval, routing and economics against the lab data boundary."
}
]
},
{
"id": "early-accepted-output-economics",
"evidenceIds": [
"E1",
"E9",
"E13",
"E21"
],
"type": "paragraph",
"text": "Price each workflow by reviewer-accepted evidence: traceable experiment summary, reproducible omics run, controlled write-back, validated calculation or safe automation command.",
"variant": "small"
},
{
"id": "early-accepted-output-caveat",
"evidenceIds": [
"E9",
"E13",
"E21"
],
"type": "paragraph",
"text": "Vendor and standards sources show workflow shape. Buyer-specific accepted-output economics require private measurement.",
"variant": "small"
},
{
"id": "early-accepted-output-cost-table",
"title": "Accepted outputs set the cost denominator",
"evidenceIds": [
"E1",
"E9",
"E13",
"E21"
],
"type": "table",
"columns": [
{
"key": "route",
"label": "Route",
"align": "left"
},
{
"key": "accepted_output",
"label": "Accepted output",
"align": "left"
},
{
"key": "hidden_cost",
"label": "Hidden cost",
"align": "left"
},
{
"key": "board_rule",
"label": "Board rule",
"align": "left"
}
],
"rows": [
{
"route": "Validated notebook, LIMS and SDMS systems",
"accepted_output": "Accepted record update, result review or controlled write-back.",
"hidden_cost": "Configuration, validation, training, reviewer queues and reapproval.",
"board_rule": "Use external systems when supplier evidence reduces validation burden."
},
{
"route": "Scientific data foundation",
"accepted_output": "Reusable dataset with raw-file anchor, metadata and lineage.",
"hidden_cost": "Parser validation, ontology work, metadata repair and source reconciliation.",
"board_rule": "Use when instruments, formats and sites make custom harmonisation brittle."
},
{
"route": "Omics workflow platform",
"accepted_output": "Reproducible run or accepted annotation with versioned inputs.",
"hidden_cost": "Workflow maintenance, consent labels, run provenance and reruns.",
"board_rule": "Use when reproducibility and access inheritance matter more than generic storage."
},
{
"route": "Automation or cloud lab",
"accepted_output": "Accepted experiment or command sequence, including failed-run evidence.",
"hidden_cost": "Simulation, physical safety, deviation handling and human release.",
"board_rule": "Pilot in research before granting regulated command authority."
},
{
"route": "Model and retrieval layer",
"accepted_output": "Accepted scientific answer or action under approved data terms.",
"hidden_cost": "Context curation, access filters, prompt logs, review time and fallback routes.",
"board_rule": "Self-host only when data boundary or output economics justify the burden."
}
]
},
{
"id": "deployment-link-bridge",
"evidenceIds": [
"E1",
"E9",
"E13",
"E21"
],
"type": "paragraph",
"text": "After the lab data boundary and accepted-output denominator are fixed, the next dependency is deployment architecture: licence, hosting, retrieval, serving engine, GPU cost and recovery route.",
"variant": "small"
},
{
"id": "related-llm-deployment-report",
"evidenceIds": [
"E1",
"E9",
"E13",
"E21"
],
"type": "report_link",
"reportId": "RPT_01KSHN11BXA9HDRNBPX41MYJ61",
"slug": "open-source-llm-deployment-options",
"label": "Deployment options for open-source LLM models",
"dek": "Deployment architecture for model licence, open-weight hosting, serving engines, retrieval control, GPU cost and accepted-output economics.",
"relation": "Related report"
},
{
"id": "route-definition-callout",
"title": "Route definition",
"evidenceIds": [
"E2",
"E9",
"E13",
"E21",
"E1"
],
"type": "callout",
"tone": "neutral",
"body": "Route means the approved path from work to accepted output: the source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger that make an AI result usable."
}
]
},
{
"id": "data-lineage",
"title": "Data lineage",
"access": "locked",
"dek": "A lab answer is only as good as the record trail behind it.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "data-lineage-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "eln-lims-sdms",
"title": "ELN, LIMS and SDMS",
"access": "locked",
"dek": "The system of record should survive the AI layer.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "eln-lims-sdms-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "omics-workflows",
"title": "Omics workflows",
"access": "locked",
"dek": "Genomic and multi-omics data need consent-aware workflow infrastructure for sequence and derived data.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "omics-workflows-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "lab-automation",
"title": "Lab automation",
"access": "locked",
"dek": "The agentic lab is an instrumentation problem before it is an AI problem.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "lab-automation-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "gxp-validation",
"title": "GxP validation",
"access": "locked",
"dek": "Validated cloud helps. Intended-use evidence still decides.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "gxp-validation-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "ip-boundaries",
"title": "IP boundaries",
"access": "locked",
"dek": "The model boundary should follow the value of the context.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "ip-boundaries-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "private-evals",
"title": "Private evals",
"access": "locked",
"dek": "Accepted scientific outputs beat demo answers.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "private-evals-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "implementation-economics",
"title": "Implementation economics",
"access": "locked",
"dek": "The unit is the accepted scientific output.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "implementation-economics-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "operating-risks",
"title": "Operating risks",
"access": "locked",
"dek": "Boundary failures outrank model embarrassments.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "operating-risks-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "recommended-next-steps",
"title": "Recommended next steps",
"access": "locked",
"dek": "Move from inventory to AI-use policy before adding more AI.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "recommended-next-steps-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "known-unknowns",
"title": "Known unknowns",
"access": "locked",
"dek": "Public evidence is good on rules and product shape, weaker on like-for-like operating economics.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "known-unknowns-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "vendor-directory",
"title": "Vendor and stack directory",
"access": "locked",
"dek": "Representative routes for shortlist building.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "vendor-directory-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "source-ledger",
"title": "Source ledger",
"access": "locked",
"dek": "Thirty primary source rows support thirty-one evidence rows; S13 carries both E13 and the E35 economics caveat.",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "source-ledger-locked",
"title": "Locked section",
"evidenceIds": [],
"type": "callout",
"tone": "locked",
"body": "Purchase or subscribe to unlock this section."
}
]
},
{
"id": "glossary",
"title": "Glossary",
"access": "sample",
"claimIds": [],
"evidenceIds": [],
"blocks": [
{
"id": "glossary-table",
"title": "Terms used in this report",
"caption": "Definitions are reader aids, not separate evidence claims.",
"evidenceIds": [],
"type": "table",
"columns": [
{
"key": "term",
"label": "Term",
"align": "left"
},
{
"key": "meaning",
"label": "Plain meaning",
"align": "left"
}
],
"rows": [
{
"term": "Route",
"meaning": "The approved path from work to accepted output: source set, data boundary, model or vendor channel, tools, reviewer, evidence record and reapproval trigger."
},
{
"term": "API",
"meaning": "Application programming interface: a governed software connection used by an app or workflow to call a model or service."
},
{
"term": "LLM",
"meaning": "Large language model: a model trained to read and generate text-like tokens."
},
{
"term": "Token",
"meaning": "A chunk of text used for billing, context windows and rate limits. It is usually smaller than a word, not a page count."
}
]
}
]
}
]
}
},
"gap_analysis": "An independent like-for-like benchmark or longitudinal telemetry set is missing for approval rate, validation effort, lineage repair, reviewer burden, failed runs, cost and accepted-output accuracy across the same lab-informatics, scientific-data-cloud, omics and automation workflow.",
"kinetics": {
"speed": "moderate",
"impact": 0.89,
"momentum": 0.77,
"businessImpact": "Lab AI infrastructure is now judged by how much notebook, sample, raw-file, omics and automation work can cross into AI use without losing lineage, rights or validation state.",
"rateOfChange": "Validation evidence can change before lab-system renewal when intended use, supplier releases, omics run provenance or consent inheritance shifts.",
"from": "compliance recordkeeping for lab systems",
"toward": "approved lab-work objects feeding governed AI use"
},
"watch_signals": [],
"sample_findings": [
"Life-sciences AI infrastructure is an approval decision across experiments, samples, instruments, omics workflows, automation and GxP evidence."
]
}
```